283 related articles for article (PubMed ID: 19287509)
1. Genome-wide association study of determinants of anti-cyclic citrullinated peptide antibody titer in adults with rheumatoid arthritis.
Cui J; Taylor KE; Destefano AL; Criswell LA; Izmailova ES; Parker A; Roubenoff R; Plenge RM; Weinblatt ME; Shadick NA; Karlson EW
Mol Med; 2009; 15(5-6):136-43. PubMed ID: 19287509
[TBL] [Abstract][Full Text] [Related]
2. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles.
Irigoyen P; Lee AT; Wener MH; Li W; Kern M; Batliwalla F; Lum RF; Massarotti E; Weisman M; Bombardier C; Remmers EF; Kastner DL; Seldin MF; Criswell LA; Gregersen PK
Arthritis Rheum; 2005 Dec; 52(12):3813-8. PubMed ID: 16320316
[TBL] [Abstract][Full Text] [Related]
3. The influence of polygenic risk scores on heritability of anti-CCP level in RA.
Cui J; Taylor KE; Lee YC; Källberg H; Weinblatt ME; Coblyn JS; Klareskog L; Criswell LA; Gregersen PK; Shadick NA; Plenge RM; Karlson EW
Genes Immun; 2014 Mar; 15(2):107-14. PubMed ID: 24385024
[TBL] [Abstract][Full Text] [Related]
4. Several regions in the major histocompatibility complex confer risk for anti-CCP-antibody positive rheumatoid arthritis, independent of the DRB1 locus.
Lee HS; Lee AT; Criswell LA; Seldin MF; Amos CI; Carulli JP; Navarrete C; Remmers EF; Kastner DL; Plenge RM; Li W; Gregersen PK
Mol Med; 2008; 14(5-6):293-300. PubMed ID: 18309376
[TBL] [Abstract][Full Text] [Related]
5. Different patterns of associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in the extended major histocompatibility complex region.
Ding B; Padyukov L; Lundström E; Seielstad M; Plenge RM; Oksenberg JR; Gregersen PK; Alfredsson L; Klareskog L
Arthritis Rheum; 2009 Jan; 60(1):30-8. PubMed ID: 19116921
[TBL] [Abstract][Full Text] [Related]
6. Peptidyl arginine deiminase type IV (PADI4) haplotypes interact with shared epitope regardless of anti-cyclic citrullinated peptide antibody or erosive joint status in rheumatoid arthritis: a case control study.
Bang SY; Han TU; Choi CB; Sung YK; Bae SC; Kang C
Arthritis Res Ther; 2010; 12(3):R115. PubMed ID: 20537173
[TBL] [Abstract][Full Text] [Related]
7. Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins.
Huizinga TW; Amos CI; van der Helm-van Mil AH; Chen W; van Gaalen FA; Jawaheer D; Schreuder GM; Wener M; Breedveld FC; Ahmad N; Lum RF; de Vries RR; Gregersen PK; Toes RE; Criswell LA
Arthritis Rheum; 2005 Nov; 52(11):3433-8. PubMed ID: 16255021
[TBL] [Abstract][Full Text] [Related]
8. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.
van Gaalen FA; van Aken J; Huizinga TW; Schreuder GM; Breedveld FC; Zanelli E; van Venrooij WJ; Verweij CL; Toes RE; de Vries RR
Arthritis Rheum; 2004 Jul; 50(7):2113-21. PubMed ID: 15248208
[TBL] [Abstract][Full Text] [Related]
9. [Association between the synovial expression of cyclic citrullinated peptide and susceptibility variants of HLA-DRB1 shared epitope alleles and PADI 4 gene single nucleotide polymorphisms in patients with rheumatoid arthritis].
Li HB; Tie N; Jia YF; Shi L; Su Y; Zhang GZ; Wang Y; Bai LJ; Zhao J; Wang J; Xiao Z
Zhonghua Yi Xue Za Zhi; 2012 Jun; 92(23):1607-11. PubMed ID: 22944128
[TBL] [Abstract][Full Text] [Related]
10. Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.
Okada Y; Yamada R; Suzuki A; Kochi Y; Shimane K; Myouzen K; Kubo M; Nakamura Y; Yamamoto K
Arthritis Rheum; 2009 Dec; 60(12):3582-90. PubMed ID: 19950296
[TBL] [Abstract][Full Text] [Related]
11. Genetic background of anticyclic citrullinated peptide autoantibody production in Hungarian patients with rheumatoid arthritis.
Poór G; Nagy ZB; Schmidt Z; Brózik M; Merétey K; Gergely P
Ann N Y Acad Sci; 2007 Sep; 1110():23-32. PubMed ID: 17911417
[TBL] [Abstract][Full Text] [Related]
12. Contribution of an adenine to guanine single nucleotide polymorphism of the matrix metalloproteinase-13 (MMP-13) -77 promoter region to the production of anticyclic citrullinated peptide antibodies in patients with HLA-DRB1*shared epitope-negative rheumatoid arthritis.
Iwamoto N; Kawakami A; Arima K; Tamai M; Nakamura H; Kawashiri SY; Kita J; Okada A; Koga T; Kamachi M; Yamasaki S; Ichinose K; Ida H; Origuchi T; Eguchi K
Mod Rheumatol; 2011 Jun; 21(3):240-3. PubMed ID: 21107991
[TBL] [Abstract][Full Text] [Related]
13. TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study.
Plenge RM; Seielstad M; Padyukov L; Lee AT; Remmers EF; Ding B; Liew A; Khalili H; Chandrasekaran A; Davies LR; Li W; Tan AK; Bonnard C; Ong RT; Thalamuthu A; Pettersson S; Liu C; Tian C; Chen WV; Carulli JP; Beckman EM; Altshuler D; Alfredsson L; Criswell LA; Amos CI; Seldin MF; Kastner DL; Klareskog L; Gregersen PK
N Engl J Med; 2007 Sep; 357(12):1199-209. PubMed ID: 17804836
[TBL] [Abstract][Full Text] [Related]
14. The HLA-DRB1 shared epitope is associated with susceptibility to rheumatoid arthritis in African Americans through European genetic admixture.
Hughes LB; Morrison D; Kelley JM; Padilla MA; Vaughan LK; Westfall AO; Dwivedi H; Mikuls TR; Holers VM; Parrish LA; Alarcón GS; Conn DL; Jonas BL; Callahan LF; Smith EA; Gilkeson GS; Howard G; Moreland LW; Patterson N; Reich D; Bridges SL
Arthritis Rheum; 2008 Feb; 58(2):349-58. PubMed ID: 18240241
[TBL] [Abstract][Full Text] [Related]
15. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.
Snir O; Widhe M; von Spee C; Lindberg J; Padyukov L; Lundberg K; Engström A; Venables PJ; Lundeberg J; Holmdahl R; Klareskog L; Malmström V
Ann Rheum Dis; 2009 May; 68(5):736-43. PubMed ID: 18635594
[TBL] [Abstract][Full Text] [Related]
16. Systematic approach demonstrates enrichment of multiple interactions between non-
Diaz-Gallo LM; Ramsköld D; Shchetynsky K; Folkersen L; Chemin K; Brynedal B; Uebe S; Okada Y; Alfredsson L; Klareskog L; Padyukov L
Ann Rheum Dis; 2018 Oct; 77(10):1454-1462. PubMed ID: 29967194
[TBL] [Abstract][Full Text] [Related]
17. The HLA-DRB1 shared epitope alleles differ in the interaction with smoking and predisposition to antibodies to cyclic citrullinated peptide.
van der Helm-van Mil AH; Verpoort KN; le Cessie S; Huizinga TW; de Vries RR; Toes RE
Arthritis Rheum; 2007 Feb; 56(2):425-32. PubMed ID: 17265477
[TBL] [Abstract][Full Text] [Related]
18. Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status.
Bang SY; Lee KH; Cho SK; Lee HS; Lee KW; Bae SC
Arthritis Rheum; 2010 Feb; 62(2):369-77. PubMed ID: 20112396
[TBL] [Abstract][Full Text] [Related]
19. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ
Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452
[TBL] [Abstract][Full Text] [Related]
20. HLA-DRB1*0404 is strongly associated with high titers of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis.
Charpin C; Balandraud N; Guis S; Roudier C; Toussirot E; Rak J; Lambert N; Martin M; Reviron D; Roudier J; Auger I
Clin Exp Rheumatol; 2008; 26(4):627-31. PubMed ID: 18799094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
